Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 381 | CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | 18,169.0 | $140K | 0.01% | +5K | +39.1% | $7.70 | +63.8% |
| 382 | GERN | GERON CORP | Healthcare | 104,020.0 | $137K | 0.01% | -8K | -7.0% | $1.32 | -3.0% |
| 383 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 22,670.0 | $137K | 0.01% | -2K | -6.9% | $6.03 | +52.4% |
| 384 | ON | ON SEMICONDUCTOR | Technology | 2,500.0 | $135K | 0.01% | -11K | -81.2% | $54.15 | +114.6% |
| 385 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 6,727.0 | $135K | 0.01% | -384.0 | -5.4% | $20.12 | +32.9% |
| 386 | JANX | JANUX THERAPEUTICS INC | Healthcare | 9,801.0 | $135K | 0.01% | -733.0 | -7.0% | $13.80 | +5.2% |
| 387 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 8,236.0 | $133K | 0.01% | -588.0 | -6.7% | $16.15 | +65.9% |
| 388 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 15,870.0 | $130K | 0.01% | -11K | -41.3% | $8.18 | +1.7% |
| 389 | AQST | AQUESTIVE THERAPEUTICS INC | Healthcare | 19,880.0 | $128K | 0.01% | -1K | -6.2% | $6.46 | -36.2% |
| 390 | GHRS | GH RESEARCH PLC | Healthcare | 10,107.0 | $128K | 0.01% | NEW | — | $12.70 | +74.2% |
| 391 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | 2,958.0 | $127K | 0.01% | -186.0 | -5.9% | $42.83 | -32.3% |
| 392 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 6,050.0 | $126K | 0.01% | -830.0 | -12.1% | $20.86 | +39.6% |
| 393 | PAHC | PHIBRO ANIMAL HEALTH CORP-A | Healthcare | 3,332.0 | $124K | 0.01% | -238.0 | -6.7% | $37.36 | -11.0% |
| 394 | REPL | REPLIMUNE GROUP INC | Healthcare | 12,782.0 | $124K | 0.01% | -900.0 | -6.6% | $9.72 | -49.5% |
| 395 | ARVN | ARVINAS INC | Healthcare | 10,465.0 | $124K | 0.01% | -2K | -18.7% | $11.86 | -23.4% |
| 396 | TMDX | TRANSMEDICS GROUP INC | Healthcare | 1,000.0 | $122K | 0.01% | — | — | $121.65 | -43.3% |
| 397 | ABSI | ABSCI CORP | Healthcare | 34,503.0 | $120K | 0.01% | +8K | +31.6% | $3.49 | +46.1% |
| 398 | RGNX | REGENXBIO INC | Healthcare | 8,249.0 | $119K | 0.01% | -605.0 | -6.8% | $14.40 | -55.9% |
| 399 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 11,893.0 | $118K | 0.01% | +2K | +25.6% | $9.93 | -48.5% |
| 400 | CTMX | CYTOMX THERAPEUTICS INC | Healthcare | 27,609.0 | $118K | 0.01% | NEW | — | $4.26 | -11.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
39.5%
Healthcare
21.2%
Communication Services
12.4%
Financial Services
10.6%
Consumer Cyclical
10.1%
Consumer Defensive
2.7%
Industrials
1.9%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%